FDA commissioner Hahn leaves agency
January 20, 2021 -- Dr. Stephen Hahn, the commissioner of the U.S. Food and Drug Administration (FDA), has left the agency. He is being replaced on an interim basis by longtime FDA regulator Dr. Janet Woodcock.  Discuss
Hexapod personal protective booths cut testing costs for COVID-19
January 19, 2021 -- As the COVID-19 pandemic continues to evolve, hospitals and labs have had to get creative, overcome hurdles, and adapt their practices to perform safer COVID-19 testing. One solution is the Hexapod, which is a personal protective booth that allows healthcare providers to undertake swab testing without physically contacting patients.  Discuss
COVID-19 pandemic accelerates adoption of diagnostic testing at point of care
January 11, 2021 -- Out of a very bad year where the COVID-19 pandemic brought the world to its knees has come some good, investors say. Point-of-care diagnostics tests are flourishing, according to panelists at the Biotech Showcase investor conference, held online from January 11-15.  Discuss
FDA warns labs that SARS-CoV-2 variant could cause false-negative test results
January 8, 2021 -- The U.S. Food and Drug Administration (FDA) has sent an alert to clinical laboratory staff and healthcare providers regarding the potential effect of SARS-CoV-2 viral mutations causing false-negative results on diagnostic tests.  Discuss
Quick decisions, expertise kept Wash. lab afloat during 1st COVID-19 hotspot
December 18, 2020 -- Quick management decisions -- and a little bit of luck -- helped the University of Washington's clinical lab keep its head above water in the early phases of the COVID-19 pandemic. Lab professionals rapidly developed their diagnostic testing and informatics response as the state became the epicenter of the first U.S. hotspot of SARS-CoV-2 infection.  Discuss
Inflammatory biomarkers help quickly size up COVID-19 patients
December 17, 2020 -- Rapid blood tests for interferon gamma-induced protein 10 and calprotectin could help in the assessment and triage of COVID-19 patients, according to poster presentations reported by test developers at the annual American Association for Clinical Chemistry meeting.  Discuss
COVID-19 challenges the landscape of rapid testing for infectious diseases
December 17, 2020 -- The future is bright for rapid testing of infectious diseases, but the COVID-19 pandemic has raised a number of challenges that must be addressed, according to speakers at a December 15 session of the American Association for Clinical Chemistry virtual meeting.  Discuss
Bottlenecks in testing supplies short-circuit U.S. COVID-19 response
December 16, 2020 -- Supply shortages have plagued the U.S. response to COVID-19 testing, and the federal government is open to new ideas for solutions, according to a presentation by White House COVID-19 testing lead Admiral Dr. Brett Giroir in a speech at the American Association for Clinical Chemistry annual meeting.  Discuss
What have labs learned from the COVID-19 pandemic?
December 15, 2020 -- If you had the chance to do it all over again, what would you do differently? Representatives from clinical labs pondered that question as it relates to the COVID-19 pandemic in a December 14 session at the American Association for Clinical Chemistry virtual meeting, offering guidance on how labs could respond to the next global health emergency.  Discuss
Low-volume test platform from Baebies wins 'disruptive tech' award at AACC
December 15, 2020 -- A diagnostic testing platform designed specifically for infants that requires a smaller blood sample beat products from two other companies to win the Disruptive Technology Award at the American Association for Clinical Chemistry (AACC) virtual annual meeting. The Finder platform from Baebies operates on a sample of just 50 µmL of blood.  Discuss